Pneumococcal surface protein A (PspA) is serologically highly variable and is expressed by all clinically important capsular serotypes of Streptococcus pneumoniae.
about
Pneumococcal and influenza vaccination: current situation and future prospectsCholine Binding Proteins from Streptococcus pneumoniae: A Dual Role as Enzybiotics and Targets for the Design of New AntimicrobialsA Review of Pneumococcal Vaccines: Current Polysaccharide Vaccine Recommendations and Future Protein AntigensStructure of a complex of human lactoferrin N-lobe with pneumococcal surface protein a provides insight into microbial defense mechanismPspA, a surface protein of Streptococcus pneumoniae, is capable of eliciting protection against pneumococci of more than one capsular typeIntranasal vaccination with pneumococcal surface protein A and interleukin-12 augments antibody-mediated opsonization and protective immunity against Streptococcus pneumoniae infection.Diversity of PspA: mosaic genes and evidence for past recombination in Streptococcus pneumoniae.The putative proteinase maturation protein A of Streptococcus pneumoniae is a conserved surface protein with potential to elicit protective immune responsesThe epidemiology of pneumococcal infection in children in the developing world.A live recombinant avirulent oral Salmonella vaccine expressing pneumococcal surface protein A induces protective responses against Streptococcus pneumoniaePppA, a surface-exposed protein of Streptococcus pneumoniae, elicits cross-reactive antibodies that reduce colonization in a murine intranasal immunization and challenge model.Differential PsaA-, PspA-, PspC-, and PdB-specific immune responses in a mouse model of pneumococcal carriage.Pneumococcal diversity: considerations for new vaccine strategies with emphasis on pneumococcal surface protein A (PspA).Identification of pneumococcal surface protein A as a lactoferrin-binding protein of Streptococcus pneumoniaePneumococcal surface protein A inhibits complement activation by Streptococcus pneumoniae.Immunization of mice with combinations of pneumococcal virulence proteins elicits enhanced protection against challenge with Streptococcus pneumoniae.Use of a whole genome approach to identify vaccine molecules affording protection against Streptococcus pneumoniae infection.Essential role for cellular phosphoglucomutase in virulence of type 3 Streptococcus pneumoniae.Characterization of binding of human lactoferrin to pneumococcal surface protein APneumococcal virulence factors: structure and functionRole of pneumococcal surface protein C in nasopharyngeal carriage and pneumonia and its ability to elicit protection against carriage of Streptococcus pneumoniaeAnalysis of serum cross-reactivity and cross-protection elicited by immunization with DNA vaccines against Streptococcus pneumoniae expressing PspA fragments from different clades.Preclinical evaluation of the Pht proteins as potential cross-protective pneumococcal vaccine antigens.Genetic alteration of capsule type but not PspA type affects accessibility of surface-bound complement and surface antigens of Streptococcus pneumoniae.Both family 1 and family 2 PspA proteins can inhibit complement deposition and confer virulence to a capsular serotype 3 strain of Streptococcus pneumoniaeImmunization of mice with pneumolysin toxoid confers a significant degree of protection against at least nine serotypes of Streptococcus pneumoniaeRegions of PspA/EF3296 best able to elicit protection against Streptococcus pneumoniae in a murine infection modelCorrelation between in vitro complement deposition and passive mouse protection of anti-pneumococcal surface protein A monoclonal antibodies.Effects of zinc deficiency and pneumococcal surface protein a immunization on zinc status and the risk of severe infection in mice.Relative roles of genetic background and variation in PspA in the ability of antibodies to PspA to protect against capsular type 3 and 4 strains of Streptococcus pneumoniaeVariation in repeat number within the alpha C protein of group B streptococci alters antigenicity and protective epitopes.Sequence heterogeneity of PsaA, a 37-kilodalton putative adhesin essential for virulence of Streptococcus pneumoniaeCharacterization of hemin binding activity of Streptococcus pneumoniae.Oral immunization with PspA elicits protective humoral immunity against Streptococcus pneumoniae infection.Rapid expansion of the physical and genetic map of the chromosome of Clostridium perfringens CPN50.C-Terminal Clostridium perfringens Enterotoxin-Mediated Antigen Delivery for Nasal Pneumococcal VaccineDevelopment of a vaccine against invasive pneumococcal disease based on combinations of virulence proteins of Streptococcus pneumoniae.Pneumococal Surface Protein A (PspA) Regulates Programmed Death Ligand 1 Expression on Dendritic Cells in a Toll-Like Receptor 2 and Calcium Dependent Manner.Effect of genetic switching of capsular type on virulence of Streptococcus pneumoniae.CcpA-dependent and -independent control of beta-galactosidase expression in Streptococcus pneumoniae occurs via regulation of an upstream phosphotransferase system-encoding operon.
P2860
Q24675532-CB795756-B92F-49FB-AF93-2518809094B5Q26744448-1B31D27B-96C1-412A-96A5-75C17037EEFDQ26753152-A59BB3B8-8838-45E6-A3A8-2BCAB4D95D4CQ27645143-75DC74EB-C13B-4BF4-BC97-64C8F0485476Q33513623-77D01D00-87CF-41DF-A755-786CD360EBE2Q33552360-55CC0169-659F-4E7A-99A1-0DD1AF634775Q33592652-E0DBA7BB-0D10-4580-B4F8-63D0D9255700Q33598106-72EEBD43-BC11-4DA1-BE79-605A8F79485CQ33655617-7FA2830D-8767-4F2B-A4B5-82ECDEE19539Q33757861-B8EF1570-5394-4758-A541-6FA9451D5688Q33795071-98E97F4B-FB88-45A4-8E23-5DE28C12FFC6Q33798317-F9580807-4B92-4276-8C70-5663796A8B38Q33975380-031BFA35-BD65-4535-B1F7-0293F65BFB9AQ34000817-3541D959-0914-4B41-8712-D044C7BF98ABQ34001813-33BB16F2-F72B-4604-9DBF-CEB35025BF34Q34004489-764E27AA-0980-4FCC-9FBF-5C7B50964DFAQ34006372-3B00E666-5B68-417D-994B-DAA67F9AA75AQ34006826-EFF8061E-3D5D-49E1-8A91-DEA187142AC1Q34007403-29231562-9B51-4D1A-9A0C-708EE2D6E6B8Q34010335-029D1DEE-CA6C-4281-BE68-2C3DAE347961Q34121334-481C7E94-D57D-446D-BEA6-DB57942CE2C7Q34130636-D68B9F81-F9C4-4BEB-A2FF-277D1A594DFBQ34484575-E1C565F4-A71E-43F9-8DFF-3860011B0C57Q34521565-5BE62784-F470-4614-8B3D-123003223B79Q34530684-2A9ACC0D-659F-44FB-AE51-A1DE746394A8Q34549615-8190DCFA-E759-4B5D-B0D7-7ADDD907563CQ34713678-CC59BCC9-057C-4653-9E6E-D44360FE85BEQ34784957-8C260463-FE56-448C-AB23-77603CCEEFFFQ34854559-2F8D063F-EFDD-4442-BF6C-5F5C25D898F3Q35165275-084E5A1F-7CC2-4C52-9227-96D32F7EBFC2Q35516451-79F82397-3A7A-4AD9-99D3-11E724048A1FQ35532255-0C9C5845-3D15-4A88-901A-15489F3CB3B3Q35544480-F376A4F7-620D-45C1-A575-7C4F07950D97Q35567265-CF3D16D7-F384-43DA-978F-04607A0057DEQ35595981-BC6B823E-E02A-444D-BD65-D2696519DA86Q35643907-B80C6F1E-20DD-46CC-AAD8-1C371D2F0BF7Q35689099-CC6A4D63-81BF-42FE-A581-EAFF47922581Q35716191-AA8211A3-B129-4C7C-A567-D42D2939ED62Q35779863-9A5DFE2B-FD21-46F7-94EA-3C5076918089Q35949387-C8B29A63-741F-43A1-8F00-39432F2AD936
P2860
Pneumococcal surface protein A (PspA) is serologically highly variable and is expressed by all clinically important capsular serotypes of Streptococcus pneumoniae.
description
1990 nî lūn-bûn
@nan
1990 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1990 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
1990年の論文
@ja
1990年論文
@yue
1990年論文
@zh-hant
1990年論文
@zh-hk
1990年論文
@zh-mo
1990年論文
@zh-tw
1990年论文
@wuu
name
Pneumococcal surface protein A ...... s of Streptococcus pneumoniae.
@ast
Pneumococcal surface protein A ...... s of Streptococcus pneumoniae.
@en
type
label
Pneumococcal surface protein A ...... s of Streptococcus pneumoniae.
@ast
Pneumococcal surface protein A ...... s of Streptococcus pneumoniae.
@en
prefLabel
Pneumococcal surface protein A ...... s of Streptococcus pneumoniae.
@ast
Pneumococcal surface protein A ...... s of Streptococcus pneumoniae.
@en
P2093
P2860
P1476
Pneumococcal surface protein A ...... s of Streptococcus pneumoniae.
@en
P2093
D E Briles
D F Talkington
J S Turner
L S McDaniel
W D Waltman
P2860
P304
P407
P577
1990-10-01T00:00:00Z